Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Location status: Recruiting
NCT Number: NCT05968807
The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M5G 1X8, Canada
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Mentee Inclusion Criteria:
Mentor Inclusion Criteria:
Exclusion criteria
iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship.
Time frame: Baseline to study completion, an average of 1 year
How many participants were recruited and have withdrawn from the program on average over time.
Time frame: Baseline to study completion, an average of 1 year
When the participant completes 10 audio or video calls over 12 weeks and 100% when all online outcome measures completed.
Time frame: Baseline to 12 weeks after baseline/immediately after the intervention
Whether the innovation is agreeable, palatable or satisfactory.
Measured via semi-structured interview or focus group.
Time frame: Baseline to program completion, an average of one year
Whether the innovation is agreeable, palatable or satisfactory.
Measured via semi-structured interview or focus group.
Time frame: Baseline to 12 weeks after baseline/immediately after the intervention
Measured via semi-structured interview or focus group.
Time frame: Baseline to program completion, an average of one year
Measured via semi-structured interview or focus group.
Time frame: Baseline to 12 weeks after baseline/immediately after the intervention
Measured via semi-structured interview or focus group.
Time frame: Baseline to program completion, an average of one year
Measured via semi-structured interview or focus group.
Time frame: Baseline to program completion, an average of one year
Parental Stress Scale; 18-item questionnaire. Each question is scored on a scale from 1 to 5, with scores ranging from 18 to 90. An overall higher score means a worse outcome.
Time frame: Baseline to program completion, an average of one year
General Anxiety Disorder-7; 7-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 21. An overall higher score means a worse outcome.
Time frame: Baseline to program completion, an average of one year
Patient Health Questionnaire Depression Scale; 8-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 24. An overall higher score means a worse outcome.
Time frame: Baseline to program completion, an average of one year
Short form version 2.0 of the PROMIS battery for: Social Isolation; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a worse outcome.
Time frame: Baseline to program completion, an average of one year
Short form version 2.0 of the PROMIS battery for: Informational Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome.
Time frame: Baseline to program completion, an average of one year
Short form version 2.0 of the PROMIS battery for: Emotional Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome.
Time frame: Baseline to program completion, an average of one year
Coping Health Inventory for Parents; 16-item questionnaire. Each question about coping behaviour is scored on a scale from 0 to 3, with a possible response of "Did not use" the coping behaviour. Scores range from 0 to 48. An overall higher score means a better outcome.
Time frame: Baseline to program completion, an average of one year
Pediatric Quality of Life Inventory™ 2.0 Family Impact Module; 36-item questionnaire with 8 different sections: Physical Functioning, Emotional Functioning, Social Functioning, Cognitive Functioning, Communication, Worry, Daily Activities, and Family Relationships. Each question is scored on a scale from 0 to 4. Items are reverse-scored and linearly transformed to a 0-100 scale. An overall higher score means a better outcome.
Contact information is provided by the study sponsor or research team.
The Hospital for Sick Children
Other
"The Isolation I Feel is Profound": The iParent2Parent Online Peer Support Program for Parents of Pediatric Solid Organ Transplantation Recipients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06529536
Solid Organ Transplant
Melbourne, Victoria, Australia
View Trial DetailsNCT05550298
Hematopoietic Cell Transplant, Respiratory Viral Infection
Birmingham, Alabama, United States
View Trial DetailsNCT07609303
Solid Organ Transplant
View Trial DetailsNCT06937463
Bed-ridden Patient, Critical Illness
Seoul, South Korea
View Trial Details